(Q33755537)

29 July 2017

Clinical trial of fusidic acid for lepromatous leprosy (English)

1 reference

29 July 2017

0 references

1 reference

S G Franzblau

1

1 reference

29 July 2017

G P Chan

2

1 reference

29 July 2017

B G Garcia-Ignacio

3

1 reference

29 July 2017

V E Chavez

4

1 reference

29 July 2017

J B Livelo

5

1 reference

29 July 2017

C L Jimenez

6

1 reference

29 July 2017

M L Parrilla

7

1 reference

29 July 2017

R F Calvo

8

1 reference

29 July 2017

D L Williams

9

1 reference

29 July 2017

T P Gillis

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

38

1 reference

29 July 2017

7

1 reference

29 July 2017

1651-1654

1 reference

Clinical trial of clarithromycin for lepromatous leprosy

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Clinical trial of sparfloxacin for lepromatous leprosy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Effect of fusidic acid on the immune response in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Susceptibility of mycobacteria to fusidic acid

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

A clinical trial of minocycline in lepromatous leprosy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Structure-Activity Relationships in Fusidic Acid-Type Antibiotics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284609

Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A

30 October 2018

1 reference

12 December 2020

Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents

1 reference

12 December 2020

Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR

1 reference

12 December 2020

Rifampicin-containing antibiotic combinations in the treatment of difficult infections

1 reference

12 December 2020

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation

1 reference

12 December 2020

The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae

1 reference

12 December 2020

Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.38.7.1651

1 reference

29 July 2017

1 reference

29 July 2017

1 reference